# U S Global Investors Inc: overview

GROW · Nasdaq · CIK 754811 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/grow.md) · [Financials](/companies/grow/financials.md) · [Filings](/companies/grow/filings.md) · [Insiders](/companies/grow/insiders.md)

Latest reported revenue: [$6.9m](/filings/0001437749-26-029613.md) for Q4 FY2026, three months to 2026-06-30, from the 10-K filed Sep 3, 2026 (XBRL us-gaap:Revenues, accession 0001437749-26-029613).

## Last eight quarters

| Line item | Unit | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [2,157](/filings/0001437749-25-034452.md) | [2,231](/filings/0001437749-26-004918.md) | [2,103](/filings/0001437749-26-019757.md) | [4,353 d](/filings/0001437749-26-029613.md) | [2,251](/filings/0001437749-25-034452.md) | [2,510](/filings/0001437749-26-004918.md) | [2,762](/filings/0001437749-26-019757.md) | [6,875 d](/filings/0001437749-26-029613.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(25.9%)](/filings/0001437749-25-034452.md) | [(24.2%)](/filings/0001437749-26-004918.md) | [(42.5%)](/filings/0001437749-26-019757.md) | [(22.9%) d](/filings/0001437749-26-029613.md) | [(22.9%)](/filings/0001437749-25-034452.md) | [(3.5%)](/filings/0001437749-26-004918.md) | [3.2%](/filings/0001437749-26-019757.md) | [(1.3%) d](/filings/0001437749-26-029613.md) |
| Net margin | % | [14.6%](/filings/0001437749-26-019757.md) | [(3.9%)](/filings/0001437749-26-019757.md) | [(18.2%)](/filings/0001437749-26-019757.md) | [(4.2%) d](/filings/0001437749-26-029613.md) | [66.9%](/filings/0001437749-26-019757.md) | [(33.7%)](/filings/0001437749-26-019757.md) | [96.9%](/filings/0001437749-26-019757.md) | [(4.1%) d](/filings/0001437749-26-029613.md) |
| Diluted EPS | $ per share | [0.02](/filings/0001437749-25-034452.md) | [(0.01)](/filings/0001437749-26-004918.md) | [(0.03)](/filings/0001437749-26-019757.md) | not reported | [0.12](/filings/0001437749-25-034452.md) | [(0.07)](/filings/0001437749-26-004918.md) | [0.21](/filings/0001437749-26-019757.md) | not reported |
| Free cash flow | $k | [16.0](/filings/0001437749-25-034452.md) | [(406) d](/filings/0001437749-26-004918.md) | [(426) d](/filings/0001437749-26-019757.md) | [(15.0) d](/filings/0001437749-26-029613.md) | not reported | not reported | [275 d](/filings/0001437749-26-019757.md) | [203 d](/filings/0001437749-26-029613.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [24.7](/filings/0001437749-23-032363.md) | [15.1](/filings/0001437749-24-028889.md) | [11.0](/filings/0001437749-25-028574.md) | [10.8](/filings/0001437749-26-029613.md) | [14.4](/filings/0001437749-26-029613.md) |
| Gross margin | % | not reported | not reported | not reported | [(4.9%)](/filings/0001437749-26-029613.md) | [25.0%](/filings/0001437749-26-029613.md) |
| Operating margin | % | [45.0%](/filings/0001437749-23-032363.md) | [23.4%](/filings/0001437749-24-028889.md) | [(4.4%)](/filings/0001437749-25-028574.md) | [(27.5%)](/filings/0001437749-26-029613.md) | [(4.2%)](/filings/0001437749-26-029613.md) |
| Net margin | % | [13.9%](/filings/0001437749-23-032363.md) | [20.9%](/filings/0001437749-24-028889.md) | [12.1%](/filings/0001437749-25-028574.md) | [(3.1%)](/filings/0001437749-26-029613.md) | [21.2%](/filings/0001437749-26-029613.md) |
| Diluted EPS | $ per share | [0.23](/filings/0001437749-23-032363.md) | [0.22](/filings/0001437749-24-028889.md) | [0.09](/filings/0001437749-25-028574.md) | [(0.03)](/filings/0001437749-26-029613.md) | [0.24](/filings/0001437749-26-029613.md) |
| Free cash flow | $m | [10.3](/filings/0001437749-23-032363.md) | [2.9](/filings/0001437749-24-028889.md) | [0.8](/filings/0001437749-25-028574.md) | [(0.8)](/filings/0001437749-26-029613.md) | [0.7](/filings/0001437749-26-029613.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/grow/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-23 | [Pilecki Derek Steven](/insiders/2137707.md) | Control Person | Purchase (P) | 4,532 | $2.5799 | $11.7k | [Form 4](/filings/0001062993-26-005547.md) |
| 2026-10-23 | [Gator Capital Management, LLC](/insiders/1570284.md) | 10% owner | Purchase (P) | 4,532 | $2.5799 | $11.7k | [Form 4](/filings/0001062993-26-005549.md) |
| 2026-10-20 | [Pilecki Derek Steven](/insiders/2137707.md) | 10% owner | Purchase (P) | 2,886 | $2.57 | $7.4k | [Form 4](/filings/0001062993-26-005478.md) |
| 2026-10-20 | [Gator Capital Management, LLC](/insiders/1570284.md) | 10% owner | Purchase (P) | 2,886 | $2.57 | $7.4k | [Form 4](/filings/0001062993-26-005480.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Gator Capital Management, LLC](/funds/1570284.md) | 2026-06-30 | $3.5m | 1,121,593 |  | Added +80,219 |
| [CWA Asset Management Group, LLC](/funds/1667134.md) | 2026-06-30 | $2.2m | 707,235 |  | Added +77,741 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.6m | 508,207 |  | Reduced −8,874 |
| [North Star Investment Management Corp.](/funds/1342857.md) | 2026-06-30 | $1.3m | 406,000 |  | Unchanged |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $961.9k | 308,300 |  | Unchanged |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $636.5k | 204,015 |  | Added +11,300 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $410.3k | 131,480 |  | Added +15,999 |
| [Rothschild Wealth LLC](/funds/1811345.md) | 2026-06-30 | $380.5k | 121,965 |  | Reduced −1,002 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $352.8k | 113,071 |  | Added +67,427 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $255.7k | 81,957 |  | Added +15,105 |

## Recent filings

[All 1,632 filings](/companies/grow/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-03 | 16:30 ET | [8-K](/filings/0001437749-26-029616.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-029616 |
| 2026-09-03 | 16:21 ET | [10-K](/filings/0001437749-26-029613.md) | Annual report, period 2026-06-30 | 0001437749-26-029613 |
| 2026-06-08 | 11:47 ET | [8-K](/filings/0001437749-26-019804.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-019804 |
| 2026-06-05 | 16:54 ET | [10-Q/A](/filings/0001437749-26-019757.md) | Quarterly report, amended, period 2026-03-31 | 0001437749-26-019757 |
| 2026-06-02 | 19:15 ET | [8-K](/filings/0001437749-26-019086.md) | 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001437749-26-019086 |
| 2026-05-13 | 16:32 ET | [8-K](/filings/0001437749-26-016753.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-016753 |
| 2026-05-13 | 16:17 ET | [10-Q](/filings/0001437749-26-016734.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016734 |
| 2026-02-20 | 16:58 ET | [8-K](/filings/0001437749-26-004929.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-004929 |
| 2026-02-20 | 16:22 ET | [10-Q](/filings/0001437749-26-004918.md) | Quarterly report, period 2025-12-31 | 0001437749-26-004918 |
| 2025-11-12 | 16:25 ET | [8-K](/filings/0001437749-25-034460.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034460 |

## Latest annual report

[Form 10-K for the fiscal year ended Jun 30, 2026](/filings/0001437749-26-029613.md), filed Sep 3, 2026.

## Forecast league

Q1 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/a48730c7-e43a-48d0-bdfc-3c3c1f2efc8f)

## About the filer

- CIK: 754811
- Tickers: GROW
- Exchange: Nasdaq
- SIC code: 6282 Investment Advice
- State of incorporation: TX
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 14:19 ET. No prices; not investment advice.